Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
Open Access
- 1 March 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 140 (5) , 1511-1518
- https://doi.org/10.4049/jimmunol.140.5.1511
Abstract
In this study, we examined the possible role of TNF-alpha and lymphotoxin (TNF-beta) as cofactors of macrophage activation. The results demonstrate that both TNF were capable of enhancing the cytostatic and cytolytic activity of murine peritoneal macrophages against Eb lymphoma cells. The potentiation of tumor cytotoxicity became apparent when macrophages from DBA/2 mice were suboptimally activated by either a T cell clone-derived macrophage-activating factor or by IFN-gamma plus LPS. Neither TNF-alpha nor TNF-beta could induce tumor cytotoxicity in IFN-gamma-primed macrophages, indicating that TNF cannot replace LPS as a triggering signal of activation. In LPS-resistant C3H/HeJ macrophages, which were unresponsive to IFN-gamma plus LPS, a supplementation with TNF fully restored activation to tumor cytotoxicity. Furthermore, TNF-alpha potentiated a variety of other functions in low-level activated macrophages such as a lactate production and release of cytotoxic factors. At the same time, TNF-alpha produced a further down-regulation of pinocytosis, tumor cell binding and RNA synthesis observed in activated macrophages. These data demonstrate new activities for both TNF-alpha and TNF-beta as helper factors that facilitate macrophage activation. In particular, the macrophage product TNF-alpha may serve as an autocrine signal to potentiate those macrophage functions that were insufficiently activated by lymphokines.This publication has 38 references indexed in Scilit:
- Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin.The Journal of Experimental Medicine, 1984
- Macrophage-activating factors from different T cell clones induce distinct macrophage functions.The Journal of Immunology, 1983
- Correction of defective macrophage differentiation in C3H/HeJ mice by an interferon-like molecule.The Journal of Immunology, 1982
- Potentiation of macrophage tumor cytostasis by tumor-induced ascites.The Journal of Immunology, 1981
- Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.The Journal of Immunology, 1981
- Interaction of Bacillus Calmette-Guérin-activated macrophages and neoplastic cells in vitroCellular Immunology, 1980
- Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cellsInfection and Immunity, 1980
- Stimulation of RNA Synthesis in L-929 Cells by Rabbit Tumor Necrosis FactorExperimental Biology and Medicine, 1979
- DEFECTIVE FC RECEPTOR-MEDIATED PHAGOCYTOSIS IN C3H-HEJ MACROPHAGES .1. CORRECTION BY LYMPHOKINE-INDUCED STIMULATION1979
- Macrophage Activation for Tumor Cytotoxicity: Development of Macrophage Cytotoxic Activity Requires Completion of A Sequence of Short-Lived Intermediary ReactionsThe Journal of Immunology, 1978